Emergent BioSolutions Inc (EBS)
8.77
-0.35
(-3.84%)
USD |
NYSE |
Nov 04, 16:00
9.01
+0.24
(+2.74%)
After-Hours: 20:00
Emergent BioSolutions Debt to Equity Ratio: 2.232 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.232 |
| March 31, 2024 | 1.364 |
| December 31, 2023 | 1.325 |
| September 30, 2023 | 1.236 |
| June 30, 2023 | 0.9445 |
| March 31, 2023 | 1.163 |
| December 31, 2022 | 1.013 |
| September 30, 2022 | 0.7268 |
| June 30, 2022 | 0.5453 |
| March 31, 2022 | 0.5289 |
| December 31, 2021 | 0.5219 |
| September 30, 2021 | 0.5575 |
| June 30, 2021 | 0.5532 |
| March 31, 2021 | 0.5642 |
| December 31, 2020 | 0.6046 |
| September 30, 2020 | 0.7027 |
| June 30, 2020 | 0.6567 |
| March 31, 2020 | 0.7343 |
| December 31, 2019 | 0.7453 |
| September 30, 2019 | 0.7956 |
| June 30, 2019 | 0.8499 |
| March 31, 2019 | 0.7519 |
| December 31, 2018 | 0.786 |
| September 30, 2018 | 0.014 |
| June 30, 2018 | 0.0144 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.0153 |
| December 31, 2017 | 0.0148 |
| September 30, 2017 | 0.3752 |
| June 30, 2017 | 0.4007 |
| March 31, 2017 | 0.4069 |
| December 31, 2016 | 0.4497 |
| September 30, 2016 | 0.489 |
| June 30, 2016 | 0.3678 |
| March 31, 2016 | 0.3706 |
| December 31, 2015 | 0.3741 |
| September 30, 2015 | 0.418 |
| June 30, 2015 | 0.45 |
| March 31, 2015 | 0.4666 |
| December 31, 2014 | 0.4537 |
| September 30, 2014 | 0.4891 |
| June 30, 2014 | 0.5146 |
| March 31, 2014 | 0.5257 |
| December 31, 2013 | 0.1266 |
| September 30, 2013 | 0.1272 |
| June 30, 2013 | 0.1347 |
| March 31, 2013 | 0.1415 |
| December 31, 2012 | 0.1422 |
| September 30, 2012 | 0.1476 |
| June 30, 2012 | 0.1482 |
| March 31, 2012 | 0.1486 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5219
Minimum
Dec 2021
2.232
Maximum
Jun 2024
0.8799
Average
0.7268
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Geovax Labs Inc | -0.0616 |
| Tonix Pharmaceuticals Holding Corp | 0.2016 |
| Abbott Laboratories | 0.3764 |
| SIGA Technologies Inc | 0.00 |
| Chimerix Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.514B |
| Total Liabilities (Quarterly) | 1.127B |
| Shareholders Equity (Quarterly) | 386.30M |
| Current Ratio | 1.056 |
| Net Debt Paydown Yield | 29.72% |